tariquidar has been researched along with 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester in 3 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester) | Trials (3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester) | Recent Studies (post-2010) (3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 69 | 0 | 61 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klinkhammer, W; Pick, A; Wiese, M | 1 |
| Bankstahl, JP; Bankstahl, M; Erker, T; Filip, T; Kuntner, C; Langer, O; Löscher, W; Mairinger, S; Müller, M; Sauberer, M; Stanek, J; Wanek, T | 1 |
| Altmann, KH; Bartholomaeus, R; Bauer, S; Bause, M; Bernhardt, G; Buschauer, A; Jackson, SM; Koenig, B; Kowal, J; Locher, KP; Manolaridis, I; Stahlberg, H; Taylor, NMI; Zechner, M | 1 |
3 other study(ies) available for tariquidar and 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester
| Article | Year |
|---|---|
Specific inhibitors of the breast cancer resistance protein (BCRP).
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Diketopiperazines; Drug Resistance, Multiple; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Imatinib Mesylate; Indoles; Neoplasm Proteins; Novobiocin; Piperazines; Pyrimidines; Quinolines; Structure-Activity Relationship | 2010 |
A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier.
Topics: Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Data Interpretation, Statistical; Diketopiperazines; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Knockout; Neoplasm Proteins; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals | 2012 |
Structural basis of small-molecule inhibition of human multidrug transporter ABCG2.
Topics: Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily G, Member 2; Binding Sites; Cholesterol; Cryoelectron Microscopy; Diketopiperazines; Drug Design; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrolysis; Indoles; Kinetics; Lipids; Molecular Structure; Neoplasm Proteins; Phospholipids; Protein Binding; Protein Multimerization; Quinolines; Structure-Activity Relationship; Substrate Specificity | 2018 |